Author

Camila Maria Longo Machado

Scientific Researcher VI, ICESP-Faculdade de Medicina USP - Cited by 806 - Oncology - Nuclear Medicine - Immunology

Biography

Camila Maria Longo Machado, Department of Anatomy, Cellular Biology, Biophysics and Physiology, Biology Institute, Campinas State University. Skills and Expertise: Immunofluorescence, Immunocytochemistry, Tumors, Cell Culture, Flow Cytometry, Immunohistochemistry, Cancer Biology, Cell Signaling, Apoptosis, Cell Proliferation
Title
Cited by
Year
High-resolution optoacoustic imaging of tissue responses to vascular-targeted therapies
K Haedicke, L Agemy, M Omar, A Berezhnoi, S Roberts, ...Nature biomedical engineering 4 (3), 286-297, 2020202
85
2020
Copper in tumors and the use of copper-based compounds in cancer treatment
DA da Silva, A De Luca, R Squitti, M Rongioletti, L Rossi, CML Machado, ...Journal of inorganic biochemistry 226, 111634, 2022202
76
2022
Inhibition of angiotensin II receptor 1 limits tumor-associated angiogenesis and attenuates growth of murine melanoma
AH Otake, AL Mattar, HC Freitas, CML Machado, S Nonogaki, ...Cancer chemotherapy and pharmacology 66, 79-87, 2010201
68
2010
Galectin-3 up-regulation in hypoxic and nutrient deprived microenvironments promotes cell survival.
RC Rafael Yamashita Ikemori, Camila Maria Longo Machado, Karina Mie Furuzawa ...plos one 9, e111592, 2014201
68
2014
Docking, Synthesis and Antiproliferative Activity of N-Acylhydrazone Derivatives Designed as Combretastatin A4 Analogues
DN do Amaral, BC Cavalcanti, DP Bezerra, PMP Ferreira, RP Castro, ...PLoS One 9 (3), e85380, 2014201
60
2014
Galectin‐3 disruption impaired tumoral angiogenesis by reducing VEGF secretion from TGFβ1‐induced macrophages
CML Machado, LNS Andrade, VR Teixeira, FF Costa, CM Melo, ...Cancer medicine 3 (2), 201-214, 2014201
55
2014
Expression of PAFR as part of a prosurvival response to chemotherapy: a novel target for combination therapy in melanoma
AC Onuchic, CML Machado, RF Saito, FJ Rios, S Jancar, R ChammasMediators of inflammation 2012, 2012201
53
2012
Preclinical anticancer effectiveness of a fraction from Casearia sylvestris and its component Casearin X: in vivo and ex vivo methods and microscopy examinations
PMP Ferreira, DP Bezerra, J do Nascimento Silva, MP da Costa, ...Journal of ethnopharmacology 186, 270-279, 2016201
50
2016
Morphological characterization of a human glioma cell l ine
CML Machado, A Schenka, J Vassallo, W Tamashiro, EM Gonçalves, ...Cancer cell international 5 (1), 1-7, 2005200
42
2005
Antitumour efficacy of Piper tuberculatum and piplartine based on the hollow fiber assay
DP Bezerra, PMP Ferreira, CML Machado, NC De Aquino, ER Silveira, ...Planta Medica 81 (01), 15-19, 2015201
38
2015
Technetium glucose complexes as potential cancer imaging agents
R Dapueto, RB Aguiar, M Moreno, CML Machado, FLN Marques, ...Bioorganic & Medicinal Chemistry Letters 25 (19), 4254-4259, 151
20
2015
Technetium-99m-or Cy7-labeled rituximab as an imaging agent for non-Hodgkin lymphoma
X Camacho, CL Machado, MF García, JP Gambini, A Banchero, ...Oncology 92 (4), 229-242, 2017201
19
2017
99mTc-Labeled Bevacizumab via HYNIC for Imaging of Melanoma
X Camacho, MF García, V Calzada, M Fernández, O Alonso, JP Gambini, ...Journal of analytical oncology 3 (1), 53-64, 2014201
13
2014
Ultrastructural characterization of the new NG97ht human‐derived glioma cell line using two different electron microscopy technical procedures
CML Machado, TQ Zorzeto, JER Bianco, RG Rosa, SC Genari, ...Microscopy Research and Technique 72 (4), 310-316, 2009200
12
2009
Characterization of cells recovered from the xenotransplanted NG97 human-derived glioma cell line subcultured in a long-term in vitro
CML Machado, RY Ikemori, TQ Zorzeto, ACMA Nogueira, SDS Barbosa, ...BMC cancer 8 (1), 1-13, 2008200
10
2008
Melatonin deficiency decreases brown adipose tissue acute thermogenic capacity of in rats measured by 18F-FDG PET
B Halpern, MC Mancini, C Mendes, CML Machado, S Prando, ...Diabetology & Metabolic Syndrome 12 (1), 1-7, 2020202
9
2020
Tocilizumab labeling with 99mTechnetium via HYNIC as a molecular diagnostic agent for multiple myeloma
Tocilizumab labeling with mTechnetium via HYNIC as a molecular diagnostic agent for multiple myelomaX Camacho, C Longo Machado, M Fernanda Garcia, M Fernández, ...Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2017201
9
2017
NDRG4 promoter hypermethylation is a mechanistic biomarker associated with metastatic progression in breast cancer patients
EHF Jandrey, RP Moura, LNS Andrade, CL Machado, LF Campesato, ...NPJ Breast Cancer 5 (1), 11, 2019201
8
2019